A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release Methylphenidate Liquid, 66 Gamma-Aminobutyric Acid (GABA) Deficit, 40 Lisdexamfetamine Dimesylate, 56 Methylphenidate and Driving, 19 Methylphenidate Vs. Atomoxetine, 62 Molindone for Conduct Problems in ADHD, 28 Neurofeedback, 53 Parental Decisions About Medication, 45 Potential Blood Test, 8 Sensory Modulation Disorder Comparison, 38 Stimulant Safety in Congenital Heart Disease, 15 Transdermal Methylphenidate in Preschoolers, 3 adverse effects Second-Generation Antipsychotics, 25 aggression Distinguishing Between Bipolar and Disruptive Behavior Disorders, 65 Treatment Recommendations, 34 agitation amnesia anhedonia Cannabinoid Receptor Gene Polymorphism, 44 Gamma-Aminobutyric Acid Levels, 15 anorexia nervosa Enhanced CBT, 61 Theory of Mind Hypoactivation, 51 anticonvulsants. See also specific drugs antipsychotics. See also specific drugs Adverse Effects of Second Generations, 25 Atypicals for Compared, 17 For Delirium, 26
anxiety disorders. See also specific disorders Attention Bias Modification, 22 Parent-Directed CBT in Young Children, 64 Pharmacotherapy, 16, 46 aripiprazole Plus Parent Training in Pervasive Developmental Disorder, 13 Asperger s syndrome Improving Social Competence, 4 atomoxetine For Vs. Methylphenidate in ADHD, 62 attention bias modification For Anxiety, 22 autism Fever During Pregnancy, 33 Improving Social Competence, 4 Oxcarbazepine for Aggression, 59 Oxytocin Nasal Spray, 49 Pharmacotherapy Evidence, 50 Probiotics, 1 SRIs and Repetitive Behavior, 27 B behavioral inhibition Parent-Directed CBT in Young Children, 64 benzodiazepines, 46 bipolar disorder Family Risk Questionnaire, 52 Initial Treatment, 28 Vs. Disruptive Behavior Disorders, 65 Vs. Severe Mood Dysregulation, 7 bullying Victimization and Self-Harm, 41 buspirone C cannabinoid receptor gene Polymorphism, Child Abuse, and Anhedonia, 44 cannabis dependence N-acetylcysteine, 37 child physical abuse Cannabinoid Receptor Gene Polymorphism and Anhedonia, 44 citalopram
Pediatric Depression, 3 clomipramine OCD Guidelines, 9 clonidine clozapine cognitive-behavioral therapy (CBT) After Sexual Abuse, 35 Anxiety Triad Disorders, 46 Computerized Game for Depression, 39 Enhanced Form for Anorexia, 61 Internet Addiction, 55 Non-Suicidal Self-Injury, 21 OCD Guidelines, 9 Parent-Directed for Preschool Anxiety, 64 computerized gaming Depression, 39 conduct disorder Neurobiology, 43 conduct problems Molindone in ADHD, 28 confusion consent to treatment Adolescents Views, 23 counterfeit drugs Adderall, 31 D delirium Atypical Antipsychotics, 26 dementia depression Acceptability of Treatments, 31 Brain Activation on fmri, 20 Citalopram and Escitalopram, 3 Parental Disorders and Adolescent Risk, 66 SPARX Play Computer Game, 39 depression, anhedonic Cannabinoid Receptor Gene Polymorphism and Child Abuse, 44 depression, melancholic Gamma-Aminobutyric Acid Levels, 15 depression, parental Predicts Adolescents Risk, 66 Preventing Problems in Children, 8
depression, paternal Affects Child Mental Health, 2 developmental delays Fever During Pregnancy, 33 developmental group psychotherapy Non-Suicidal Self-Injury, 21 dialectical behavior therapy Non-Suicidal Self-Injury, 21 disability, childhood Mental Health Issues, 46 disorientation disruptive behavior disorders Neurobiology, 43 Vs. Bipolar Disorder, 65 divalproex Initial Treatment for Bipolar Disorder, 28 dopamine transporter Alterations in ADHD, 14 drug approval Extended-Release Methylphenidate Liquid, 66 E, F enuresis, nocturnal Imipramine for Risperidone-Associated, 4 escitalopram Pediatric Depression, 3 exposure and response prevention therapy Adjunct in Tourette Syndrome, 63 family risk questionnaire Diagnosing Bipolar Disorder, 52 fever In Pregnancy and Offspring Autism, 33 fluoxetine Anxiety Disorders, 16 fluphenazine fluvoxamine For folate Deficiency and Mood Disorders, 40 fragile X syndrome Sertraline and Language Development, 57 functional MRI Brain Activation in Depression, 20
G Gamma-aminobutyric acid (GABA) Deficit in ADHD, 40 Reduced In Anhedonia, 15 gender identity disorder Review, 47 generalized anxiety disorder Pharmacotherapy, 46 GI dysfunction Probiotics in Autism, 1 guanfacine Adjunctive in ADHD, 11 guidelines Pediatric OCD, 9 Psychodynamic Psychotherapy, 29 Sexual Orientation Issues, 55 Treatment of Maladaptive Aggression in Youths, 34 H L haloperidol homocysteine Deficiency and Mood Disorders, 40 imipramine Risperidone-Associated Enuresis, 4 internet addiction CBT, 55 irritability lisdexamfetamine dimesylate ADHD, 56 lithium Initial Treatment for Bipolar Disorder, 28 loxapine M membrane potential ratio ADHD Blood Test, 8 methylphenidate Extended-Release Liquid, 66 Vs. Atomoxetine in ADHD, 62 methylphenidate, transdermal Driving Safety, 19 In Preschool Children, 3 mirtazapine mixed amphetamine salts Counterfeit Adderall, 31 molindone Conduct Problems in ADHD, 28
N N-acetylcysteine For Cannabis Dependence, 37 negativism neurocognitive impairment Treatment Target in At-Risk Youths, 20 neurofeedback ADHD, 53 non-suicidal self-injury Treatments, 21 O obsessive-compulsive disorder New Practice Parameter, 9 olanzapine omega-3 fatty acids In Tourette Syndrome, 32 oppositional defiant disorder Neurobiology, 43 oxcarbazepine For Aggression in Autism, 59 oxytocin Nasal Spray in Autism, 49 P panic disorder Parental Disorders and Adolescent Risk, 66 panic disorder, parental Predicts Adolescents Risk, 66 parent training In Pervasive Developmental Disorder, 13 paroxetine pervasive developmental disorder Combined Pharmacotherapy and Parent Training, 13 phobias posttraumatic stress disorder (PTSD) preschool social/emotional problems New Screening Instrument, 52 probiotics Potential Usefulness in Autism, 1
problem solving therapy Non-Suicidal Self-Injury, 21 psychodynamic psychotherapy Practice Parameter, 29 psychosis Drug Treatment of Early-Onset, 58 Vitamin D Deficiency, 35 psychosocial treatments Maladaptive Aggression, 34 psychotherapy Acceptability of Depression Treatments, 31 Q, R quetiapine Adolescent Schizophrenia, 63 risperidone Imipramine for Nocturnal Enuresis, 4 Initial Treatment for Bipolar Disorder, 28 Maladaptive Aggression, 34 Plus Parent Training in Pervasive Developmental Disorder, 13 S schizophrenia Drug Treatment of Early-Onset, 58 Neurocognitive Impairment, 20 Quetiapine in Adolescents, 63 selective serotonin reuptake inhibitors (SSRIs). See also specific drugs, 46 OCD Guidelines, 9 self-harm Bullying Victimization, 41 In Late Adolescence, 10 Non-Suicidal, 21 sensory modulation disorder ADHD Comparison, 38 separation anxiety disorder Pharmacotherapy, 46 serotonin reuptake inhibitors. See also specific drugs Ineffective for Repetitive Behavior, 27 sertraline
Language Development in Fragile X Syndrome, 57 severe mood dysregulation Vs. Bipolar Disorder, 7 sexual abuse CBT Efficacy, 35 sexual orientation issues Practice Parameter, 55 social phobia Pharmacotherapy, 46 social skills In High-Functioning Autism, 4 SPARX Play Computerized Game for Depression, 39 stimulants. See also specific drugs Maladaptive Aggression, 34 Safety in Congenital Heart Disease, 15 substance abuse/dependence N-acetylcysteine for Cannabis Dependence, 37 sudden unexplained death Stimulants in Congenital Heart Disease, 15 T Z theory of mind Hypoactivation in Anorexia, 51 thioridazine tics Fatty Acids in Tourette Syndrome, 32 Tourette syndrome Adjunctive Exposure and Response Prevention Therapy, 63 Fatty Acids, 32 tricyclic antidepressants Anxiety Triad Disorders, 46 trifluoperazine valproate venlafaxine, 46 vitamin B Deficiency and Mood Disorders, 40 vitamin D Deficiency and Psychotic Symptoms, 35